- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Non-Transitional Cell Carcinoma of the Urothelial Tract
Total 7500 results
-
University of British ColumbiaRecruitingTransitional Cell Cancer of the Renal Pelvis and Ureter | Urothelial Carcinoma of the Renal Pelvis and UreterCanada
-
UroGen Pharma Ltd.RecruitingCarcinoma, Transitional Cell | Urothelial Carcinoma | Urothelial Cancer of Renal Pelvis | Urothelial Carcinoma Ureter | Urothelial Carcinoma Recurrent | Urothelial Carcinoma of the Renal Pelvis and Ureter | Urothelial Carcinoma Ureter Recurrent | Transitional Cell Carcinoma of Renal PelvisUnited States
-
Memorial Sloan Kettering Cancer CenterNovartisCompletedMetastatic Transitional Cell Carcinoma of the UrotheliumUnited States
-
Memorial Sloan Kettering Cancer CenterAstraZenecaCompletedAdenocarcinoma of the Bladder | Squamous Cell Carcinoma of the Bladder | Metastatic Bladder Cancer | Non-Transitional Cell Carcinoma of the Urothelial Tract | Small Cell of the BladderUnited States
-
Academisch Medisch Centrum - Universiteit van Amsterdam...CompletedTransitional Cell Carcinoma of Urinary TractNetherlands
-
UroGen Pharma Ltd.Tanner Pharma GroupAvailableUrothelial Carcinoma | Urothelial Cancer of Renal Pelvis | Urothelial Carcinoma Ureter | Urothelial Carcinoma Recurrent | Urothelial Carcinoma of the Renal Pelvis and Ureter | Urothelial Carcinoma Ureter Recurrent
-
Clinique Beau SoleilCepheid; Team Languedoc Mutualité / Nouvelles technologiesCompletedNon-Invasive Bladder Urothelial Carcinoma | Non-Invasive Bladder Papillary Urothelial Carcinoma, Low Grade | Non-Invasive Bladder Papillary Urothelial Carcinoma, High GradeFrance
-
Pierre Fabre MedicamentBristol-Myers SquibbCompletedBladder Cancer | Bladder Neoplasms | Transitional Cell Carcinoma of the Urothelial TractCanada
-
Tata Memorial CentreNot yet recruitingNon-Invasive Bladder Urothelial Carcinoma
-
Leonard ApplemanSanofi-SynthelaboCompletedMetastatic Transitional Cell Cancer of the Urothelial TractUnited States
-
National Cancer Institute (NCI)TerminatedMetastatic Transitional Cell Cancer of the Renal Pelvis and Ureter | Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter | Regional Transitional Cell Cancer of the Renal Pelvis and Ureter | Transitional Cell Carcinoma of the Bladder | Localized Transitional Cell Cancer of the...United States
-
RenJi HospitalCompletedNeoadjuvant Immunotherapy of Cisplatin-ineligible High Risk Upper Urinary Tract Urothelial CarcinomaChina
-
H. Lee Moffitt Cancer Center and Research InstituteUnited States Department of DefenseRecruitingUrothelial Carcinoma | Non-Invasive Bladder Urothelial CarcinomaUnited States
-
University of Texas Southwestern Medical CenterRecruitingUrothelial Cancer of Renal Pelvis | Urothelial Carcinoma UreterUnited States
-
UroGen Pharma Ltd.WithdrawnCarcinoma | Transitional Cell Carcinoma | Transitional Cell Cancer of the Renal Pelvis and UreterIsrael, United States
-
Fox Chase Cancer CenterCompletedMuscle Invasive Bladder Cancer | High Risk Urothelial Carcinoma of the Upper Urinary TractsUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingTransitional Cell Carcinoma | Metastatic Urothelial Carcinoma | Unresectable Transitional Cell CarcinomaUnited States
-
National Cancer Institute (NCI)CompletedMetastatic Transitional Cell Cancer of the Renal Pelvis and Ureter | Recurrent Bladder Cancer | Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter | Stage IV Bladder Cancer | Transitional Cell Carcinoma of the Bladder | Squamous Cell Carcinoma of the BladderUnited States
-
Association Pour La Recherche des Thérapeutiques...Roche Pharma AGCompletedRecurrent Bladder Cancer | Stage IV Bladder Cancer | Transitional Cell Carcinoma of the BladderFrance, Belgium
-
Sandy SrinivasGlaxoSmithKlineCompletedBladder Cancer | Bladder (Urothelial, Transitional Cell) Cancer | Bladder (Urothelial, Transitional Cell) Cancer Resectable (Pre-Cystectomy) | Bladder (Urothelial, Transitional Cell) Cancer Superficial (Non-Invasive) | Bladder (Urothelial, Transitional Cell) Cancer Metastatic or UnresectableUnited States
-
University of California, DavisMerck Sharp & Dohme LLCCompletedRecurrent Bladder Carcinoma | Stage III Urethral Cancer | Stage IV Urethral Cancer | Urethral Urothelial Carcinoma | Stage IV Bladder Urothelial Carcinoma | Metastatic Urothelial Carcinoma of the Renal Pelvis and Ureter | Stage III Bladder Urothelial Carcinoma | Recurrent Urothelial Carcinoma of... and other conditionsUnited States
-
McMaster UniversityNot yet recruitingUrothelial Cancer of Renal Pelvis | Urothelial Carcinoma Ureter
-
The European Uro-Oncology GroupCentre for Human Drug Research, NetherlandsRecruitingUpper Tract Urothelial CarcinomaNorway, Spain, Netherlands
-
Incyte CorporationHoffmann-La Roche; Genentech, Inc.TerminatedUC (Urothelial Cancer) | NSCLC (Non-small Cell Lung Carcinoma)United States
-
YULISUOno Pharmaceutical Co. LtdRecruitingUpper Urinary Tract Urothelial CarcinomaTaiwan
-
National Cancer Institute (NCI)CompletedMetastatic Transitional Cell Cancer of the Renal Pelvis and Ureter | Recurrent Bladder Cancer | Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter | Regional Transitional Cell Cancer of the Renal Pelvis and Ureter | Stage III Bladder Cancer | Stage IV Bladder Cancer | Transitional...Canada
-
Jinling Hospital, ChinaRecruitingCarcinoma | Upper Tract Urothelial Carcinoma | UTUCChina
-
Noah Hahn, M.D.Pfizer; Hoosier Cancer Research NetworkTerminatedTransitional Cell Carcinoma of the BladderUnited States, United Kingdom
-
Hoosier Cancer Research NetworkBristol-Myers SquibbCompletedTransitional Cell Carcinoma of the BladderUnited States
-
TJ Biopharma Co., Ltd.WithdrawnFirst-line Non-small-cell Lung Cancer | First-line Urothelial Carcinoma | Second-line Urothelial Carcinoma | Second-line MelanomaChina
-
AnchorDx Medical Co., Ltd.Peking University First Hospital; Peking Union Medical College Hospital; Peking... and other collaboratorsRecruitingUpper Tract Urothelial CarcinomaChina
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingUpper Tract Urothelial CarcinomaUnited States
-
RenJi HospitalUnknown
-
Associació per a la Recerca Oncologica, SpainUnknownUrothelium Transitional Cell CarcinomaSpain, Netherlands
-
Xiangya Hospital of Central South UniversityHunan Cancer Hospital; The Third Xiangya Hospital of Central South University; Hunan Provincial People's Hospital and other collaboratorsCompletedHigh-Grade Upper Tract Urothelial CarcinomaChina
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)CompletedHigh Grade Upper Tract Urothelial CarcinomaUnited States
-
Dana-Farber Cancer InstituteGilead SciencesActive, not recruitingBladder Cancer | Urothelial Cancer | Metastatic Urothelial Carcinoma | Metastatic Urothelial Carcinoma of the Renal Pelvis and UreterUnited States
-
Hopital FochCompleted
-
Lipac Oncology LLCTesoRx Pharma, LLCCompletedUrologic Neoplasms | Urogenital Neoplasms | Urologic Diseases | Urinary Bladder Diseases | Urinary Bladder Neoplasms | Bladder Cancer | Transitional Cell Carcinoma of the Bladder | Non-Muscle Invasive Bladder Cancer | Urinary Bladder | Bladder Cancer Cell TransitionalUnited States
-
Oncolytics BiotechWithdrawnMuscle-invasive Transitional Cell Carcinoma of the Bladder
-
Erasmus Medical CenterMerck Sharp & Dohme LLCActive, not recruitingBiomarkers | Transitional Cell Carcinoma of the BladderNetherlands
-
National Cancer Institute (NCI)TerminatedMetastatic Transitional Cell Cancer of the Renal Pelvis and Ureter | Recurrent Bladder Cancer | Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter | Regional Transitional Cell Cancer of the Renal Pelvis and Ureter | Stage III Bladder Cancer | Stage IV Bladder Cancer | Transitional... and other conditionsUnited States
-
RenJi HospitalXiangya Hospital of Central South University; Shanghai Zhongshan Hospital; West... and other collaboratorsRecruitingUpper Tract Urothelial Carcinoma Receiving Kidney-sparing TherapyChina
-
Federation of Italian Cooperative Oncology GroupsRecruitingCarcinoma, UrothelialItaly
-
University of UtahNational Cancer Institute (NCI)RecruitingMetastatic Urothelial Carcinoma | Locally Advanced Urothelial Carcinoma | Unresectable Urothelial Carcinoma | Infiltrating Urothelial Carcinoma, Sarcomatoid VariantUnited States
-
Mamta ParikhNational Cancer Institute (NCI); Karyopharm Therapeutics IncRecruitingMetastatic Urothelial Carcinoma | Locally Advanced Urothelial Carcinoma | Advanced Urothelial Carcinoma | Refractory Urothelial CarcinomaUnited States
-
Merck Sharp & Dohme LLCActive, not recruitingMetastatic Urothelial Carcinoma | Urothelial NeoplasmsAustralia, United States, Canada, Chile, France, Israel, Italy, Korea, Republic of, Netherlands, Spain, Taiwan, United Kingdom
-
National Cancer Institute (NCI)CompletedRecurrent Transitional Cell Cancer of the Renal Pelvis and Ureter | Transitional Cell Carcinoma of the Bladder | Ureter Cancer | Recurrent Urethral CancerUnited States
-
Incyte CorporationTerminatedMetastatic Urothelial Carcinoma | Unresectable Urothelial CarcinomaSpain, France, United States, Italy, Japan, Ireland, Slovakia, Austria, Belgium, Canada, Finland, Germany, Poland, Portugal, Romania, United Kingdom
-
Mabwell (Shanghai) Bioscience Co., Ltd.Not yet recruitingAdvanced Urothelial CarcinomaChina